Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

China

The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu

Huashan Hospital, Shanghai

Shanghai Tenth People's Hospital, Shanghai